Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
146.80    -3.80 (-2.52%)
Bid:
148.20
Ask:
150.00
Spread: 1.80 (1.215%)
Market Cap: £250.75m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Full year trading update

14 Jul 2022 07:00

RNS Number : 3993S
McBride PLC
14 July 2022
 

14 July 2022

 

McBride plc

 

Full year trading update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning and hygiene markets, today provides the following trading update for the twelve months ended 30 June 2022.

 

Throughout the year the Group experienced both exceptional input cost inflation and supply chain disruptions, most recently further exacerbated by the Ukraine war. 

 

These impacts have been predominantly offset through pricing actions.

 

As a result, following first half revenue declines of 6.6% on a constant currency basis, revenue grew by 13.4% in the second half to produce Group revenue growth of 2.9% at constant currency for the full year. 

 

The Group anticipates that adjusted operating profit will be in line with current market consensus (*).

 

Net debt, including IFRS 16 leases, closed at circa £168m (30 June 2021: £118.4m). The Group's liquidity at 30 June 2022 was circa £70m, £30m higher than the minimum liquidity requirement of £40m applicable under the Group's financing arrangements.

 

The increase in debt was driven by;

 

· Working capital increases directly resulting from the effects of inflation rolled up in net working capital

· In-year losses

 

The Group continues to explore and assess all avenues to maintain liquidity and create additional funding for the benefit of all stakeholders.

 

We are fully appreciative of the ongoing support that the banking group have and are continuing to give the Group through this period of uncertainty caused by macroeconomic factors which have resulted in rapid and unprecedented rises in input costs and ongoing global supply chain challenges.

 

We expect to announce our year-end results on 29 September 2022.

 

 

(*) Current market consensus refers to full-year Group adjusted operating profit as compiled from broker notes.

 

For further information, please contact:

McBride plc

 

Chris Smith, Chief Executive Officer

0161 203 7570

Mark Strickland, Chief Finance Officer

0161 203 7570

FTI Consulting LLP

020 3727 1017

Ed Bridges, Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQXLFFLDLBBBK
Date   Source Headline
20th Nov 20254:40 pmRNSAGM Statement
20th Nov 20257:00 amRNSAGM Trading Update and Share Buyback
18th Nov 20259:42 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSTotal Voting Rights
27th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20256:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20257:00 amRNSApplication for Additional Listing of Shares
17th Oct 20256:23 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSRedemption of B Shares
19th Sep 20257:00 amRNSDirector/PDMR Shareholding
18th Sep 20259:04 amRNSEx-dividend date - Correction
17th Sep 20257:00 amRNSFinal Results
5th Sep 20257:00 amRNS-RInvestor Webinar on 18 September 2025
16th Jul 20257:00 amRNSFull Year Trading Update
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSHolding(s) in Company
29th May 20253:19 pmRNSHolding(s) in Company
23rd May 20251:42 pmRNSHolding(s) in Company
19th May 20257:00 amRNSHolding(s) in Company
12th May 20257:00 amRNSHolding(s) in Company
6th May 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
22nd Apr 20257:00 amRNSHolding(s) in Company
8th Apr 20257:00 amRNSHolding(s) in Company
28th Feb 20255:00 pmRNSHolding(s) in Company
25th Feb 20257:00 amRNSHalf-year Report
18th Feb 20256:15 pmRNSHolding(s) in Company
11th Feb 20254:40 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTrading Statement
29th Nov 20247:00 amRNSSuccessful Completion of Refinancing
18th Nov 20241:10 pmRNSDirector/PDMR Shareholding
18th Nov 20241:09 pmRNSDirector/PDMR Shareholding
15th Nov 20241:10 pmRNSDirector/PDMR Shareholding
12th Nov 20246:36 pmRNSResult of Annual General Meeting
12th Nov 20247:00 amRNSAGM Trading Update
6th Nov 20243:53 pmRNSDirector/PDMR Shareholding
31st Oct 20247:00 amRNSDirector/PDMR Shareholding
25th Oct 20243:48 pmRNSDirector/PDMR Shareholding
8th Oct 20246:25 pmRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSAnnual Financial Report
1st Oct 20245:30 pmRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20243:38 pmRNSDirector/PDMR Shareholding
20th Sep 20245:17 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDirector/PDMR Shareholding
17th Sep 20247:00 amRNSFinal Results
16th Jul 20247:00 amRNSFull Year Trading Update
3rd Jul 20242:33 pmRNSHolding(s) in Company
14th Jun 20247:00 amRNSGrant and vesting of RSU Awards to PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.